Back
ESC Professional Premium Access

Trends in P2Y12 inhibitor use after acute coronary syndromes: insights from the ProACS registry

Session: New perspectives in cardiology (4) - Thrombosis, platelets, and coagulation in coronary disease
Topic: Pharmacotherapy
Speaker: Doctor A. Aguiar Neves (Vila Nova de Gaia, PT)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Ana Ines Aguiar Neves

Hospital Center of Vila Nova de Gaia/Espinho, Vila Nova de Gaia (Portugal)
1 presentation
0 follower

9 more presentations in this session

Discussant - Thrombosis, platelets, and coagulation in coronary disease

Access
Like
Thumbnail

Tissue factor, a membrane-associated biomarker of platelet activation, predicts 5-year cardiovascular mortality in coronary artery disease patients

Speaker: Professor M. Camera (Milan, IT)

Access
Abstract
Like
Thumbnail

Impact of fibrin and atheroma on prognosis in acute coronary syndrome: Insights from thrombectomy specimens

Speaker: Mr H. Nohara (Sakai, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Thrombus aspiration reduces myocardial infarct size in patients with STEMI and high thrombus burden

Speaker: Doctor A. Del Torto (Milano, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Is spontaneous pre-hospital coronary reperfusion in STEMI safe ?

Speaker: Doctor P. Meunier (Montpellier, FR)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

New perspectives in cardiology (4) - Thrombosis, platelets, and coagulation in coronary disease

Speakers: Doctor A. Aguiar Neves, Professor M. Camera, Mr H. Nohara, Doctor A. Del Torto, Doctor P. Meunier
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources